US Patent Issued to GEISTLICH PHARMA on Jan. 27 for "Processes for preparing oxathiazin-like compounds" (Swiss Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,443, issued on Jan. 27, was assigned to GEISTLICH PHARMA AG (Wolhusen, Switzerland).

"Processes for preparing oxathiazin-like compounds" was invented by Rolf W. Pfirrmann (Weggis, Switzerland), Hanns Moehler (Maennedorf, Switzerland) and Thomas Mueller (Wolhusen, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Oxathiazin-like compounds, processes for making new oxathiazin-like compounds, compounds useful for making oxathiazin-like compounds, and their uses are disclosed. Processes of treating patients suffering from cancers, bacterial infections, fungal infections and/or viral infections by administering oxathiazin-like compounds are also...